Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

Dec 18, 2020 13:09 JST

Source: Eisai

Eisai Completes Construction of the 5th Manufacturing Building at Kawashima Industrial Park in Japan

To Strengthen Its in-House Production Function for Formulating Anti-Cancer Agent Lenvima?

TOKYO, Dec 18, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced that it has completed construction of the 5th manufacturing building at the Kawashima Industrial Park located in Gifu Prefecture, Japan.

External views of the 5th manufacturing building

The 5th manufacturing building is a facility specifically designated for formulating anti-cancer drugs (total floor area: approximately 4,500m2). Since anti-cancer drugs are highly active, this building is designed to make it possible to manufacture anti-cancer agents more safely, with various preventive features for controlling highly active substances, such as preventing cross-contamination of agents and exposure to workers. Eisai plans to manufacture its in-house discovered and developed anti-cancer agent Lenvima, which are in increasing demand worldwide, at this facility from FY2021. We also secure space for further installation of manufacturing equipment for other anti-cancer drugs within this building. The total investment for the construction of the 5th manufacturing building is approximately 5 billion yen.

The Kawashima Industrial Park, opened in 1966, is Eisai?s global pharmaceutical manufacturing base. In addition, this Industrial Park is a role model factory for our global production activities, where we are making new progresses such as utilizing digital technology and new technologies. With the completion of the 5th manufacturing building, Eisai will further expand the stable supply system of high-quality pharmaceuticals in Japan, and continues further contribution to improve the benefits of patients and their families in Japan and around the world.

Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Source: Eisai
Sectors: BioTech

Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

TANAKA PRECIOUS METAL GROUP Co., Ltd.

TANAKA PRECIOUS METAL NEXT Certified as a Special Subsidiary
Apr 16, 2026 21:00 JST

Toyota Motor Corporation

Isuzu and Toyota to Jointly Develop Japan's First Mass-produced Light-duty Fuel Cell Electric Truck
Apr 16, 2026 15:53 JST

Honda Motor Co, Ltd

Honda to Begin Sales of All-new Insight EV

Apr 16, 2026 15:31 JST

Hitachi, Ltd.

Hitachi Energy and Samsung C&T expand strategic collaboration to accelerate grid infrastructure and reinforce energy security
Apr 15, 2026 18:17 JST

Mitsubishi Motors

Mitsubishi Motors' Outlander PHEV Ranks No. 1 in Japan's PHEV Sales Category for the Second Consecutive Year
Apr 15, 2026 18:01 JST

Denso

DENSO Establishes Strategic Partnership with Oracle to Modernize Core Supply Chain Systems
Apr 15, 2026 11:25 JST

Fujitsu and Chugoku Electric Power T&D sign IP licensing agreement to accelerate renewable energy integration and advance power transmission maintenance
Apr 15, 2026 11:07 JST

Seres Group Co., Ltd.

Seres Cements Luxury EV Leadership with Record Sales and RMB12.51 Billion R&D Investment
Apr 14, 2026 10:29 JST

Mint Incorporation Limited

Axonex Intelligence' AI Robotics Series Makes a Splash at InnoEX
Apr 13, 2026 19:33 JST

SuperX AI Technology Limited

SuperX Japan Global Supply Center Completes First Batch Delivery, Marking Strategic Partnership Milestone in Japan
Apr 13, 2026 16:52 JST

Alpha Growth plc

Alpha Growth plc: Alpha Longevity Management launches U.S. specialty finance strategy for Japanese institutional investors, led by former members of Nikko Asset Management's team
Apr 13, 2026 16:00 JST

NEC Corporation

IFS and NEC to Deploy Next-Generation Core System IFS Cloud for Hoshizaki
Apr 10, 2026 10:10 JST

NEC Corporation

NEC's Automated Negotiation AI recognized as a Use Case in Gartner(R) Research
Apr 09, 2026 13:41 JST

Mitsubishi Motors

Mitsubishi Motors Launches the Xforce in Malaysia
Apr 08, 2026 20:47 JST

Mitsubishi Heavy Industries, Ltd.

MHI and Algomatic Win Second Place in the NEDO GENIAC-PRIZE Program
Apr 08, 2026 12:03 JST

Mitsubishi Heavy Industries, Ltd.

MHI Receives Contract for Renewal of APM System ATL SkyTrain at Hartsfield-Jackson Atlanta International Airport
Apr 07, 2026 16:42 JST

Mitsubishi Corporation

JFE Holdings and Mitsubishi Corporation Sign Second MOU to Advance Integrated Power and Data Center Project in Ohgishima, Keihin District
Apr 06, 2026 14:27 JST

NEC Corporation

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Apr 03, 2026 12:33 JST

Hitachi, Ltd.

Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player
Apr 03, 2026 11:09 JST

OMRON Corporation

OMRON Healthcare and UCSF launch AFib trial
Apr 03, 2026 00:00 JST

More Latest Release >>